Compare ACHV & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | UHT |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.0M | 595.1M |
| IPO Year | 2018 | 1995 |
| Metric | ACHV | UHT |
|---|---|---|
| Price | $6.10 | $43.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $14.67 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 2.2M | 140.0K |
| Earning Date | 05-11-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $99,190,000.00 |
| Revenue This Year | N/A | $2.12 |
| Revenue Next Year | N/A | $2.94 |
| P/E Ratio | ★ N/A | $120.25 |
| Revenue Growth | N/A | ★ 0.18 |
| 52 Week Low | $2.38 | $35.26 |
| 52 Week High | $7.11 | $46.30 |
| Indicator | ACHV | UHT |
|---|---|---|
| Relative Strength Index (RSI) | 51.78 | 57.08 |
| Support Level | $4.09 | $42.17 |
| Resistance Level | $7.11 | $44.46 |
| Average True Range (ATR) | 0.40 | 0.95 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 38.86 | 54.39 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.